Targeting the activin receptor 1C on CD4+ T cells for cancer immunotherapy,OncoImmunology

当前位置： X-MOL 学术 › Oncoimmunology › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Targeting the activin receptor 1C on CD4+ T cells for cancer immunotherapy
OncoImmunology ( IF 7.2 ) Pub Date : 2024-01-08 , DOI: 10.1080/2162402x.2023.2297503
Ying Zheng _{1,

2} , Andriana Lebid _{1,

2} , Liam Chung _{1,

2} , Juan Fu _{1,

2} , Xiaoxu Wang _{1,

2} , Andrea Otrocol _{1,

2} , Jelani C. Zarif _{1,

2} , Hong Yu _{1,

2} , Nicolas J. Llosa _{1,

2} , Drew M. Pardoll _{1,

2}

Affiliation

Activins, members of the TGF-beta superfamily, have been isolated and identified in the endocrine system, but have not been substantially investigated in the context of the immune system and endocr...

中文翻译：